Hutchmed china news
Web12 apr. 2024 · HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM, HKEX: 13) today announces that new and updated clinical and non-clinical data related to five HUTCHMED investigational drug candidates will be presented during the … Web12 apr. 2024 · HUTCHMED Limited gab bekannt, dass neue und aktualisierte klinische und nicht-klinische Daten zu fünf Arzneimittelkandidaten von HUTCHMED auf der Jahrestagung 2024 der American Association for Cancer ...
Hutchmed china news
Did you know?
Web2 dagen geleden · HUTCHMED (China) Limited announced that Dr. Karen Jean Ferrante has informed the Company that she would retire from the Board at the forthcoming annual general meeting of the Company to be held on May 12, 2024 (“AGM”), and that she would not be seeking re-election at the AGM so that she could devote more time to her … WebEVENTS, PRESENTATIONS & CIRCULARS. Annual General Meeting 2024 2024-05-12. Corporate Presentation for Investors 2024-03-31. 2024 Full Year Financial Results 2024 …
Web31 mrt. 2024 · (Alliance News) - Hutchmed (China) Ltd zei vrijdag dat het de rollende indiening van een nieuwe geneesmiddelenaanvraag voor zijn kankermedicijn fruquintinib … Web4 mrt. 2024 · Hutchison China MediTech, or Chi-Med, has been used as our group identity, while Hutchison MediPharma has been the identity of our novel drug R&D 43 operations under which our oncology products...
Web2 dagen geleden · HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM: HCM, HKEX: 13) today announces that new and updated ... Web30 mei 2024 · Hutchmed China completes enrolment for solveplenib clinical trial 3 January 2024 13:47 All company news Recent trades Trades by volume Recent trade data is unavailable. We will be replacing...
Web11 apr. 2024 · HUTCHMED (China) Limited heeft aangekondigd dat Dr. Karen Jean Ferrante de Onderneming heeft meegedeeld dat zij zich bij de komende jaarlijkse …
Web12 apr. 2024 · HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in … almere drontenWeb11 apr. 2024 · HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 11, 2024 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM, HKEX: 13) today announces that new and updated clinical and non-clinical data related to five HUTCHMED investigational drug candidates will be presented during the … almere economieWebHONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 04, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; … almere fashion domeWeb3 jan. 2024 · HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM, HKEX: 13) today announces that it has completed patient enrollment of ESLIM-01, a pivotal Phase III clinical trial of sovleplenib for the treatment of adult patients with primary … almere essenWeb2 mei 2024 · Conference call. HUTCHMED will host a conference call at 8:00 am EDT / 1:00 pm BST / 8:00 pm HKT on Monday, May 2, 2024. Participants may join the call as follows: +1 212 444 0378 (U.S.) / +44 20 ... almere doetinchemWeb2 dagen geleden · HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM, HKEX: 13) today announces that new and updated ... almere duivenWebHUTCHMED (Nasdaq/AIM:HCM;HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development … almere fiscaal